Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Risperidone at low dosage is often used as treatment of acute anxiety symptom. However,
patients may be either responder or not. Here we hypothesized that the early response to a
low dose of risperidone is predictive to risperidone efficiency.
Subjects with acute anxiety symptoms (Hospital anxiety depression scale) and risperidone
prescription would be proposed to be enrolled in the study. A check-up is made at D0, then
the subjects begin the treatment (0.5mg risperidone). The same check-up is carried out on the
following day (D1). The subjects fulfil a last check-up 12 week after the beginning of
treatment (W12). During the D1-W12, the psychiatrist may changes the treatment.